EUVIMED · CrossrefZeitschrift
EJNMMI Research
ISSN 2191-219X · Springer Science and Business Media LLC
Neueste Artikel
Calibrated fractional uptake rate to estimate cerebral glucose consumption: a simplified approach less sensitive to inter-frame motion than patlak analysis
Hematologic changes under [¹⁷⁷Lu]Lu-DOTA-TATE PRRT in GEP-NETs: a long-term longitudinal cohort study
Correction: First-in-human radiation dosimetry of the GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in patients with prostate and breast cancer
Addition of arterial-phase contrast-enhanced CT to 99mTc-sestamibi SPECT/CT improves pre-operative localisation of parathyroid adenomas
Association of [123I]I-PARPi SPECT/CT imaging and PARP immunohistochemical analysis in different cancers
Evaluation of dynamic total-body [68Ga]Ga-HER2 Affibody PET/CT in HER2-positive breast cancer: biodistribution, dosimetry and earliest feasible imaging time
High lesion detection rates with preoperative ⁹⁹ᵐTc-PSMA-SPECT/CT prior to radioguided surgery in biochemical recurrence: a hypothesis-generating analysis of quantitative PSMA-PET/CT parameters
Comparing [18F]FDG and [68Ga]Ga-FAPI-04 in two canine cases of histiocytic sarcoma
In-human assessment of target engagement and blockade of radiolabeled BI 765063, an anti-SIRPα antibody
Retrospective study of FAPI imaging in bone metastases: diagnostic utility and therapeutic relevance across cancer types in a single-center real-world cohort
[18F] Al -NOTA-FAPI-46 and [18F] FDG PET/CT in detecting postoperative residual and metastatic lesions of papillary thyroid cancer: a head-to-head comparative study
Effects of motion and white matter hyperintensities on reference region based ¹⁸F-SynVesT-1 PET quantification in Alzheimer’s disease and healthy volunteers
First-in-human radiation dosimetry of the GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in patients with prostate and breast cancer
Reconstruction matters: influence of EARL standards and BSREM in [18F]FET PET for distinguishing glioma progression from treatment-related changes
Simultaneous partial volume correction and denoising of brain PET images, using transformers and transfer learning
Preliminary study of FAP-targeted radiopharmaceuticals based on covalent targeting strategy and pharmacokinetic characteristics
Cell surface oncofetal antigens in prostate cancer: therapeutic potential and radioligand targeting
Dosimetric analysis reveals rapid clearance and low absorbed dose of [¹⁷⁷Lu]Lu-PSMA-617 in non-prostate cancers with high PSMA expression
Non-inferiority of automated deep learning-based [18F]FDG PET/CT tumour volume compared to manual GTV for prognostic modelling in head and neck cancer
225Ac-NOTA-trastuzumab human dosimetry using inter-radionuclide and biological half-life based allometric extrapolation method
Evaluation of [89Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in Chinese patients: a Phase 1 clinical study (ZIRDOSE-CP)
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism
A preclinical study on the influence of linkers in [68Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression
MRI ensemble model of plaque and perivascular adipose tissue as PET-equivalent for identifying carotid atherosclerotic inflammation
Kinetics of the amino acid uptake tracer O-(2-[18F]fluoroethyl)-L-tyrosine (FET) in human brain
Evaluation of myocardial fibrosis and wall motion abnormality with 68Ga-FAPI PET/MR in coronary heart disease
The impact of patient hydration and forced diuresis on [18F]PSMA-1007 urinary bladder uptake in PET/CT imaging
PET imaging of hepatocellular carcinoma with [124I]IV-14
Heart ketone metabolism under acute ketone supplementation in ZDF rats, a type 2 diabetes heart failure model
In silico analysis of radiation-induced double-strand breaks by internal ex vivo irradiation of lymphocytes for 45 alpha- and beta/gamma-emitting radionuclides
EUVIMED